Kronos Bio, Inc. (KRON)
NASDAQ: KRON · Real-Time Price · USD
0.8900
+0.0390 (4.58%)
Apr 28, 2025, 4:00 PM EDT - Market closed
Kronos Bio Market Cap
Kronos Bio has a market cap or net worth of $54.26 million as of April 28, 2025. Its market cap has decreased by -19.38% in one year.
Market Cap
54.26M
Enterprise Value
-32.49M
1-Year Change
-19.38%
Ranking
Category
Stock Price
$0.89
Market Cap Chart
Since the IPO on October 9, 2020, Kronos Bio's market cap has decreased from $1.00B to $54.26M, a decrease of -94.59%. That is a compound annual growth rate of -47.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 51.88M | -9.49% |
| Dec 31, 2024 | 57.32M | -21.36% |
| Dec 29, 2023 | 72.90M | -20.92% |
| Dec 30, 2022 | 92.18M | -87.96% |
| Dec 31, 2021 | 765.76M | -54.25% |
| Dec 31, 2020 | 1.67B | 67.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 794.31B |
| UnitedHealth Group | 381.06B |
| Johnson & Johnson | 371.93B |
| AbbVie | 329.14B |
| Novo Nordisk | 272.76B |
| Abbott Laboratories | 223.47B |
| AstraZeneca | 214.65B |
| Novartis AG | 211.71B |